Zoeken

Virtuvax' innovation in vaccine industry “vaccine development skating on start-ups”

Ernst Soethout
14 feb 2017
1 minuten om te lezen

Read the article written by Louis Garguilo of Outsourced Pharma about innovation in the vaccine industry and the role of our company Virtuvax. Garguilo talked with Virtuvax’ CEO Ernst Soethout on innovation in the vaccine industry, on the intended role of Virtuvax for start-ups and even on skating. The result is a snappy interview, please find a link here.

Recente blogposts

Alles weergeven

Mucosis Announces Re-issue of Major Patent by US Patent Office USPTO

Patented technology applied in SynGEM, a needle-free nasal spray vaccine against respiratory syncytial virus * Re-Issuance of U.S. Patent...

SynGEM publication paper of the month on ReSViNET

First-in-Human Results of SynGEM Demonstrate that the RSV Vaccine Is Well-Tolerated and Capable of I

SynGEM a needle-free nasal spray vaccine against respiratory syncytial virus * SynGEM shown to be safe and immunogenic in healthy adults...

Virtuvax' innovation in vaccine industry “vaccine development skating on start-ups”

Recente blogposts

Featured Posts

Virtuvax for collaboration on your innovation in vaccine development or your biosimilar